Gene693232
MIR647: microRNA 647
Cite this record
ConductScience Library. MIR647: microRNA 647. Genes, record 693232. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/693232
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
NIH grants35
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR647 papers | Newest fiscal year |
|---|---|---|---|
| K12GM081259 | IRACDA at the University of Pennsylvania: Penn Postdoctoral Opportunities in Research and Teaching (PennPORT). | 1 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 1 | 2025 |
| P30CA138292 | Winship Cancer Institute Cancer Center Support Grant | 1 | 2025 |
| P30ES009089 | Center for Environmental Health in Northern Manhattan | 1 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 1 | 2025 |
| UL1TR002366 | Frontiers Clinical and Translational Science Institute at the University of Kansas | 1 | 2025 |
| P01AG014449 | Neurobiology of Mild Cognitive Impairment in the Elderly | 1 | 2024 |
| P30ES000002 | Harvard Chan School NIEHS Center for Environmental Health | 1 | 2024 |
| P30EY031631 | Center Core Grant for Vision Research | 1 | 2024 |
| P20GM103639 | Mentoring Translational Cancer Research in Oklahoma | 2 | 2022 |
Source NIH's project files
Papers209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical biochemical significance of STAT6, ERG, and miR-647 expression in prostate cancer: Associations with tumor aggressiveness and patient prognosis. | J Med Biochem | 2026 | 42781455 | PubTator, text mining | PubMed |
| [Retracted] Tumor promoter role of miR‑647 in gastric cancer via repression of TP73. | Mol Med Rep | 2026 | 42563686 | PubTator, text mining | PubMed |
| Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression. | J Cell Mol Med | 2026 | 41652992 | PubTator, text mining | PubMed |
| Comprehensive transcriptomics and proteomics analysis of neointima formation in human saphenous vein: implications for bypass graft disease. | Am J Physiol Heart Circ Physiol | 2026 | 41569144 | PubTator, text mining | PubMed |
| Circular RNA circAHSA1 serves as a stable serum biomarker for the diagnosis and progression of gastric cancer. | Transl Oncol | 2026 | 41330006 | PubTator, text mining | PubMed |
| Non-coding RNAs PROX1-AS1 and miR-647: Potential Interaction and Prognostic Value in Gastric Cancer. | Curr Mol Med | 2026 | 40326038 | PubTator, text mining | PubMed |
| Resveratrol Sensitizes Temozolomide-Resistant Glioblastoma Cells Through Mitogen-Activated Protein Kinase Pathway Inhibition and P-Glycoprotein Modulation. | Drug Res (Stuttg) | 2025 | 41253172 | PubTator, text mining | PubMed |
| Decoding the functional roles of circular RNAs linked to NF-κB pathway in carcinogenesis. | Discov Oncol | 2025 | 40996665 | PubTator, text mining | PubMed |
| Beyond linear: How circRNAs twist and turn Notch signaling. | J Cell Commun Signal | 2025 | 40761890 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Potential of Circulating miR-1301-3p, miR-106a-5p, miR-129-5p, miR-3613-3p, and miR-647 microRNAs in Gastric Cancer. | Biochemistry (Mosc) | 2025 | 40609990 | PubTator, text mining | PubMed |
Expression109
This gene's TPM, transcripts per million, in Gene expression: up to six groups of each list, the highest median first.
Median TPM of MIR647
TPM · Band: first to third quartile · Dot: median
By normal tissue · 6 of 51
By tumor and normal adjacent tissue · 6 of 57
By cell line · 1 of 1
| Group | Samples | Samples that pass QC | Median TPM | First quartile | Third quartile | Share with TPM of 1 or more |
|---|---|---|---|---|---|---|
| Ovary | Normal tissue | 195 | 39.6 | 29.6 | 48.7 | 1 |
| Brain - Cerebellum | Normal tissue | 533 | 37.5 | 26.9 | 48.6 | 0.994 |
| Thyroid | Normal tissue | 687 | 35.1 | 27.4 | 43.5 | 1 |
| Fallopian Tube | Normal tissue | 9 | 34 | 20.4 | 45.4 | 1 |
| Nerve - Tibial | Normal tissue | 636 | 33.6 | 26.5 | 41.6 | 1 |
| Cervix - Endocervix | Normal tissue | 10 | 32.2 | 25.5 | 35.8 | 1 |
| Acute Myeloid Leukemia | Tumor | 173 | 20.8 | 14.7 | 29.2 | 1 |
| Esophageal Carcinoma | Tumor | 184 | 10.9 | 6.78 | 16.2 | 1 |
| Ovarian Serous Cystadenocarcinoma | Tumor | 420 | 9.19 | 4.67 | 16.2 | 0.974 |
| Rectum Adenocarcinoma | Tumor | 167 | 7.13 | 4.03 | 13.2 | 0.988 |
| Stomach Adenocarcinoma | Tumor | 393 | 7.07 | 3.93 | 11.5 | 0.967 |
| Colon Adenocarcinoma | Tumor | 502 | 6.21 | 2.91 | 10.3 | 0.92 |
| K-562 | Cell line | 198 | 8.26 | 6.65 | 11.7 | 1 |
Gene expression release expression-atlas-2026-11-21-0.10.0
Gene expression so far: 43,590 genes, 8,834 studies and 359,840 samples, in release expression-atlas-2026-11-21-0.10.0. Its first release holds GTEx's 19,214 samples, TCGA's 11,348 and 7 SRA projects.
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0.
The results shown here are in whole or part based upon data generated by the TCGA Research Network. TCGA's samples and their metadata come through recount3 from NCI's Genomic Data Commons, https://gdc.cancer.gov, as open data under NIH's Genomic Data Sharing Policy.
recount3, Wilks and colleagues, Genome Biology 2021, https://doi.org/10.1186/s13059-021-02533-6.
The library is for research and education. It is not medical advice. Do not use it to diagnose or treat anyone. Library terms of use
None in this release
- Proteins
- Pathways
- Patents
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/693232
GET https://conductscience.org/api/genes/v1/693232/grants?page=2